In patients with ARDS and treatment with veno-venous ECMO, high endogenous plasma concentrations of Hp could compensate for the negative effects of disease- and therapy-associated high plasma concentrations of CFH [17]. This evidence concerns the gene HP and acute respiratory distress syndrome.